We are live on
!
Find out more
BM
Brandywine Managers Portfolio holdings
AUM
$170M
1-Year Est. Return
10.01%
This Fund
S&P 500
This Quarter
Est. Return
+23.04%
1 Year Est. Return
+10.01%
3 Year Est. Return
+53.1%
5 Year Est. Return
+7.42%
10 Year Est. Return
+248.69%
AUM
$101M
AUM Growth
+$17.3M
(+21%)
Cap. Flow
+$6.72K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
84.01%
Holding
36
New
1
Increased
3
Reduced
8
Closed
–
Top Buys
| 1 |
Viking Therapeutics
VKTX
|
+$213K |
| 2 |
Klaviyo
KVYO
|
+$138K |
| 3 |
Beam Therapeutics
BEAM
|
+$127K |
| 4 |
MongoDB
MDB
|
+$115K |
Top Sells
| 1 |
SentinelOne
S
|
+$155K |
| 2 |
Veeva Systems
VEEV
|
+$124K |
| 3 |
Advanced Micro Devices
AMD
|
+$87.1K |
| 4 |
Okta
OKTA
|
+$85.4K |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$36K |
Sector Composition
| 1 | Technology | 50.63% |
| 2 | Healthcare | 10.84% |
| 3 | Financials | 1% |
Similar funds
CF
DBFM
CAS
FH
RWFS
RFO
DWM
AGC
Brandywine Managers's Q2 2025 Portfolio in Review
As of Q2 2025, Brandywine Managers held 36 positions worth $101M, up 21% from $83.4M the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 2.8%. Brandywine Managers opened 1 new position and made no exits, leaving the 36-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 46% a quarter earlier, followed by Healthcare and Financials.
- Brandywine Managers's largest Q2 2025 buy was Viking Therapeutics: 8,082 shares worth $214K.
- Brandywine Managers added most to Klaviyo in Q2 2025, an estimated $138K increase.
- Brandywine Managers's biggest Q2 2025 reduction was SentinelOne, cutting an estimated $155K.
- Brandywine Managers's ten largest holdings make up 84% of its $101M portfolio in Q2 2025.
- Brandywine Managers opened 1 new position and closed 0 in Q2 2025.
- Brandywine Managers's portfolio value rose 21% quarter-over-quarter to $101M.
Based on Brandywine Managers's 13F filing for Q2 2025, filed 14 Aug 2025.